3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Terminated
1
Completed
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other
1
Conditions
Neoplasms
2
Vomiting
1
Stomatitis
1
Rectal Neoplasms
1
Prostatic Neoplasms
1
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Neoplasm Metastasis
1
Nausea
1
Mucositis
1
Mesothelioma
1
Mastocytosis, Cutaneous
1
Lymphoma, Non-Hodgkin
1
Lymphoma, Large B-Cell, Diffuse
1
Lymphoma, B-Cell
1
Lung Neoplasms
1
Leukemia
1
Colonic Neoplasms
1
Carcinoma, Non-Small-Cell Lung
1
Burkitt Lymphoma
1
Interventions
Radiotherapy
3
Cisplatin
3
Radiation
2
pegfilgrastim
1
hydrated silica gel-based toothpaste
1
glucarpidase
1
angiotensin I (1-7)
1
aluminum hydroxide, magnesium hydroxide, drug combination
1
Surveys and Questionnaires
1
Surgical Procedures, Operative
1
Selenomethionine
1
Neck Dissection
1
Methotrexate
1
Lidocaine
1
Leucovorin
1
Ketamine
1
Granulocyte Colony-Stimulating Factor
1
Glutamine
1
Fluorouracil
1
Filgrastim
1
Fibroblast Growth Factor 7
1
Everolimus
1
Docetaxel
1
Diphenhydramine
1
Curcumin
1
Amifostine
1
Acupuncture Therapy
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Terminated
×
Mucositis
×
Diphenhydramine
×
Clear all
NCT02606994
2019-02-06
TPvsM
Oral Defense, LLC
Phase 2
Terminated
1 enrolled